Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin

Journal of Hepatology

Volumn 30, Issue 6, 1999, Pages 979-983

  Barrett, Sharon ^b   Ryan, Eleanor ^b   Crowe, John ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b NONE

Author keywords

Chronic HCV infection; DRB1*01; Hepatitis C virus (HCV); Spontaneous viral clearance

Indexed keywords

HLA DR ANTIGEN; RHESUS D ANTIBODY;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IRELAND; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL;

EID: 0033064363     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80249-9     Document Type: Article

References (26)

1. Seeff LB. Natural history of hepatitis C. Hepatology. 26:(Suppl. 1):1997;21S-28S.
2. Van der Poel CL, Cuypers HT, Reesink HW, Weiner AJ, Quan S, Di Nello R, et al. Confirmation of hepatitis C virus infection by second generation four-antigen recombinant immunoblot assay and polymerase chain reaction. Lancet. 337:1991;317-319.
3. Gordon SC, Elloway RS, Dmuchowski CF. The pathology of hepatitis C as a function of mode of transmission: blood transfusion versus intravenous drug use. Hepatology. 18:1993;1338-1343.
4. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M. Quantification of hepatitis C virus by competitive reverse transcription polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology. 18:1993;16-20.
5. Okada S-I, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology. 16:1992;619-624.
6. Takada N, Takase S, Enomoto N, Takada A, Date T. Clinical backgrounds of patients having different types of hepatitis C virus genotypes. J Hepatol. 14:1992;35-40.
7. Thuraz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas AC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B in the Gambia. N Engl J Med. 332:1995;1065-1069.
8. Steel CM, Ludlam CA, Beatson D, Peutherer JF, Cuthbert RJ, Simmonds P, et al. HLA haplotype A1 B8 DR3 as a risk factor for HIV related disease. Lancet. i:1988;1185-1188.
9. Aikawa T, Kojima M, Onishi H, Tamura R, Fukuda S, Sukuki T, et al. HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C. J Med Virol. 49:1996;274-278.
10. Hohler T, Gerken G, Notghi A, Knolle P, Lubjuhn R, Taheri H, et al. MHC Class II genes influence the susceptibility to chronic active hepatitis C. J Hepatol. 27:1997;259-264.
11. Czaja AJ, Carpenter H, Santrach PJ, Moore SB. DR human leukocyte antigens and disease severity in chronic hepatitis C. J Hepatol. 24:1996;666-673.
12. Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T, Nakatani S, et al. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology. 27:1998;240-244.
13. Alric L, Fort M, Izopet J, Vinel JP, Charlet JP, Selves J, et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gasteroenterology. 113:1997;1675-1681.
14. Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson P. Association between HLA class II genotype and spontaneous clearance of hepatitis C viremia. J Hepatol. 29:1998;214-223.
15. Minton EJ, Smillie D, Neal KR, Irving WL, Underwood JC, James V, Members of the Trent Hepatitis C Virus Study Group . Association between MHC class II alleles and clearance of circulating hepatitis C virus. J Infect Dis. 178:1998;39-44.
16. Power JP, Lawlor E, Davidson F, Holmes EC, Yap PL, Kenny-Walsh E, et al. Hepatitis C viremia in recipients of Irish intravenous anti-D immunoglobulin. Lancet. 344:1994;1166-1167.
17. Tribunal of Enquiry. Report of the Tribunal of Enquiry into the Blood Transfusion Service Board. 1997;Government Publications Office, Dublin, Ireland.
18. Middleton D, Williams F. Caucasian Northern Irish Normal. Terasaki P, Gjertson D, . HLA 1997. 1997;213 UCLA Tissue Typing Laboratory, Los Angeles, USA.
19. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
20. Desmet VJ, Gerber MA, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 19:1994;1513-1520.
21. Svejgaard A, Ryder LP. HLA and disease association; detecting the strongest association. Tissue Antigens. 43:1994;18-27.
22. Congia M, Clemente MG, Dessi C, Cucca F, Mazzoleni AP, Frau F, et al. HLA class II genes in chronic hepatitis C virus infection and associated immunological disorders. Hepatology. 24:1996;1338-1341.
23. Tibbs C, Donaldson P, Underhill J, Thomson L, Manabe K, Williams R. Evidence that the HLA DQA1*03 allele confers protection from chronic HCV infection in Northern European Caucasoids. Hepatology. 24:1996;1342-1345.
24. Peano G, Menardi G, Ponzetto A, Fenoglio LM. HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection. Arch Intern Med. 154:1994;2733-2736.
25. Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B, et al. T and B cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia. Hepatology. 24:1996;790-795.
26. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 346:1995;1006-1007.